ARTICLE | Company News
SGP receives desloratadine approvable letter
January 26, 2001 8:00 AM UTC
Schering-Plough (SGP) received an approvable letter from the FDA for its desloratadine H-1 receptor antagonist. The nonsedating antihistamine received European approval earlier this month to treat sea...